-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
MoonLake Immunotherapeutics annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2021 to 31 Dec 2025.
- MoonLake Immunotherapeutics Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $73,122,000, a 43% increase year-over-year.
- MoonLake Immunotherapeutics annual Net Cash Provided by (Used in) Financing Activities for 2025 was $145,997,000, a 185% increase from 2024.
- MoonLake Immunotherapeutics annual Net Cash Provided by (Used in) Financing Activities for 2024 was $51,312,000, a 89% decline from 2023.
- MoonLake Immunotherapeutics annual Net Cash Provided by (Used in) Financing Activities for 2023 was $479,701,000, a 301% increase from 2022.